BONITO INDUSTRIES INC
8-K, 1997-08-27
BLANK CHECKS
Previous: MONETTA TRUST, NSAR-A, 1997-08-27
Next: EGRET INC, 10QSB, 1997-08-27



 



                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15 (d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  August 22, 1997


                             BONITO INDUSTRIES, INC.
              -----------------------------------------------------
             (Exact name of Registrant as specified in its charter)

                                     Nevada
           ----------------------------------------------------------
          (State or other jurisdiction of Incorporation or organization


      33-55254-21                                        87-0438453
- ------------------------                  ------------------------------------
(Commission File Number)                  (I.R.S. Employer Identification No.)

 1508 Brookhollow Drive, Suite 354, Santa Ana, California             92705
- ------------------------------------------------------------------------------
 (Address of principal executive offices)                           (Zip Code)

                                 (714) 429-1041
              ---------------------------------------------------- 
              (Registrant's telephone number, including area code)

Bonito Industries, Inc., 3098 South Highland Dr. #460, Salt Lake City, UT 84106
- -------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)



<PAGE>

Item 2. Acquisition or Disposition of Assets.

     On August 21, 1997,  the  Registrant  executed a definitive  Agreement (the
"Acquisition  Agreement") with Laboserv s.r.l a corporation  organized under the
laws of the Republic of San Marino ("Laboserv"), under which the Registrant will
acquired  100% of all  rights,  title and  interest,  in and to the  License and
Distribution Agreement between Laboserv and Pace Diagnostics,  an Ontario Canada
Corporation. Under the terms of the License and Distribution Agreement, Laboserv
is appointed  as the sole and  exclusive  distributor  for the sale of HIV-Logic
Test in all of the countries normally referred to as being in Europe and Russia.

     Pursuant to the  Acquisition  Agreement the Registrant  acquired the rights
under said License and Distribution  Agreement in exchanged for 3,000,000 shares
of the Registrant's common stock.

     The  acquisition  was been  approved  by the  boards  of  directors  of the
Registrant and Laboserv and was completed and closed on August 22, 1997.

Item 7. Financial Statements, Pro Forma Financial Statements And Exhibits

     (b) Pro Forma Financial Information

     The Pro Forma  Consolidated  Financial  Statements  taking into account the
acquisition of the rights under the above  referenced  License and  Distribution
Agreement are not being filed with this Report but shall be filed pursuant to an
amendment to this Report within sixty (60) days.

     (c) Exhibits.

     1 Agreement between the Registrant and Laboserv dated August 21, 1997.

                                     Page 2
<PAGE>


                                   SIGNATURES

     Pursuant  to the  requirements  of  Section  13 or 15(d) of the  Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the Undersigned, thereunto duly authorized.

                                    BONITO INDUSTRIES INC.
                                   (Registrant)


Date: August 27, 1997              /S/  Gunter Herbert Bonsch
                                   --------------------------------------
                                   By: Gunter Herbert Bonsch
                                   Its:  President



Date: August 27, 1997              /S/  Dr. Klaus Schulz
                                   -------------------------------------
                                   By: Dr. Klaus Schulz
                                   Its: Secretary and Chief Financial Officer


                                     Page 3
<PAGE>



                                                       
                                    AGREEMENT

     THIS AGREEMENT,  made and entered into in Las Vegas,  Nevada sets forth the
plan of reorganization as of the 21st day of August, 1997, by and between BONITO
INDUSTRIES,   INC.,  a  Nevada  corporation,   herein  called  "PURCHASER",  and
EURO-AMERICAN GMBH and LABOSERVE GMBH,  corporations organized under the laws of
German, hereinafter jointly called "SELLER".

PLAN OF REORGANIZATION

     This plan of reorganization shall be a reorganization within the meaning of
IRC (1987), Section 368(a)(1)(B) as amended. PURCHASER shall acquire 100% of all
right,  title and interest,  in the license and distribution  agreement  between
Pace Corp. (Licensor) and Laboserv (Licensee) dated 06/23/97 and attached hereto
as Exhibit 1, by the  shareholders  of SELLER in  exchange  solely for a part of
PURCHASER'S voting common stock. It is understood and agreed by the parties that
the transaction  contemplated  herein is termed a "shell transaction" or reverse
merger/acquisition,  the purpose of which is to provide a public  trading market
for  the  shares  of  PURCHASER/SELLER  once  the  acquisition   transaction  is
completed.

AGREEMENT

     In  order  to  consummate  the  foregoing  plan  of  reorganization  and in
consideration  of the mutual  benefits  to be derived  therefrom  and the mutual
agreements  hereinafter  contained,  PURCHASER and SELLER approve and adopt this
agreement  and plan of  reorganization  effective the closing date of August 22,
1997, and mutually covenant and agree with each other as follows:

SHARES TO BE TRANSFERRED AND SHARES TO BE ISSUED

     On the closing  date,  set herein to be August 22,  1997,  PURCHASER  shall
issue 3,000,000 shares of PURCHASER'S common stock bearing a restrictive legend.
As of the date hereof,  there are issued and outstanding one million (1,000,000)
shares of common stock.  It is understood by SELLER that  PURCHASER is presently
authorized to issue 100,000,000 shares of common stock.  SELLER/PURCHASER  agree
that there will be no reorganizations,  recapitalizations,  reverse stock splits
which would have a dilutive effect on the public shareholders for a period of 18
months from the execution of this Agreement.

     In  exchange  for  PURCHASER'S  stock  being  issued  to  SELLER  as  above
described,  SELLER  shall on the closing  date and  contemporaneously  with such
issuance  of  PURCHASER'S   common  stock  deliver  to  PURCHASER  100%  of  the
outstanding common stock of SELLER.

     All   negotiations   relative  to  this  agreement  and  the   transactions
contemplated  hereby have been conducted with the assistance of CAPITAL  GENERAL
CORPORATION  who is acting as a broker,  finder and consultant on behalf of both
PURCHASER  and SELLER.  Both  PURCHASER  and SELLER  agree to hold  harmless and
indemnify CAPITAL GENERAL CORPORATION from any and all claim,  demand,  cause of
action or suit raised or filed in connection  with the operation or promotion of
PURCHASER and/or SELLER and the trading of PURCHASER/SELLER's shares.

                                     Page 1
<PAGE>

REPRESENTATIONS AND WARRANTIES OF SELLER

     To the best  knowledge of the  parties,  no  representation  or warranty by
PURCHASER in this agreement, nor any statement, certificate, schedule or exhibit
hereto furnished or to be furnished by or on behalf of SELLER to this agreement,
nor  any  document  or  certificate  delivered  to  PURCHASER  pursuant  to this
agreement or in connection with actions contemplated  hereby,  contains or shall
contain any untrue  statement of material fact or omits or shall omit a material
fact necessary to make the statement contained therein not misleading.

     SELLER understands and agrees that PURCHASER is without  substantial assets
or  liabilities  and with its public  shareholders  is thus defined  herein as a
public "shell"  corporation.  SELLER  understands and agrees that PURCHASER is a
"shell" corporation and makes no claim on any assets owned by PURCHASER previous
to the closing contemplated herein.

     There are no legal,  administrative or other proceedings,  or other claims,
judgments,   injunctions  or  restrictions,   either   threatened,   pending  or
outstanding  against or involving  PURCHASER or SELLER which are known, or which
they have reasonable grounds to know, of any basis for any such proceedings,  or
other  claims,  judgments,  injunctions  or  restrictions,   except  as  in  the
Prospectus  attached  hereto as Exhibit B and made a part of this  Agreement  or
otherwise  disclosed  herein.  Specifically,  a  "Complaint  and  Order  Denying
Exemptions and to Cease and Desist in the Matter of Capital General Corporation,
David Rex Yeaman et al. filed by the State of New Jersey in January,  1994. This
matter was resolved as disclosed in the  Company's  Form 10-Q/A  filing with the
SEC dated  November  28,  1994.  Also,  on  February 8, 1996,  David R.  Yeaman,
formerly  Secretary/Treasurer  and a Director  of the Company was charged in the
U.S.  District Court for the Eastern  District of Pennsylvania  with conspiracy,
wire fraud and fraud in the offer, purchase and sale of securities, in violation
of 18 U.S.C. Sec., 2, 371 and 1343, 15 U.S.C. Sec. 77q(a), 77x, 78j(b) and 78ff,
and 17 C.F.R. Sec.  240.10b-5  (1986);  and, that, on April 16, 1997, Mr. Yeaman
was  convicted of one count of  conspiracy,  five counts of wire fraud and three
counts of  securities  fraud;  and,  that  while Mr.  Yeaman  has  resigned  his
affiliation with Bonito Industries, Inc., Yeaman Enterprises and Capital General
Corporation,  it is  contemplated  that he  will  provide  assistance  as may be
necessary  for an orderly  transition of their affairs and he may continue to be
deemed an  affiliate  of the Company by virtue of his  familial  and  historical
relationships with the Company, its shareholders, officers and directors.

     However,  SELLER  acknowledges and represents that he is aware of the risks
of being a public company and  understands  and agrees that  regulatory  efforts
regarding  public shell  transactions  similar to the  transaction  contemplated
herein  has  been  and is  currently  being  exerted  by some  states,  the U.S.
Securities and Exchange  Commission  and the National  Association of Securities
Dealers, Inc. (NASD).  PURCHASER agrees to provide any supplemental  information
which may be requested by SELLER relating to any matter  discussed  herein or in
the Prospectus  attached hereto as Exhibit B.  PURCHASER/SELLER  understands and
agrees that once this  transaction  is  completed,  it will be a public  company
subject to the extensive, complex state, federal and NASD securities regulations

                                     Page 2

<PAGE>

incumbent on public companies.  In particular,  the parties understand and agree
that a Form 8-K must be filed with the United  States  Securities  and  Exchange
Commission  within fifteen days after closing which filing requires that audited
financial  statements be filed within sixty days after the filing of the 8-K and
that such  responsibility  shall not be the  responsibility  of Capital  General
Corporation,  its officers,  directors or employees nor the existing officers of
PURCHASER,  but the sole  responsibility  of the new officers  and  directors of
PURCHASER.

     SELLER  acknowledges  that they have carefully  evaluated  their  financial
resources and investment position and the risks associated with this transaction
and  acknowledges  that  they  are  able  to bear  the  economic  risks  of this
transaction.  SELLER further acknowledges that their knowledge and experience in
financial  and  business  matters in general,  and  investments  in  particular,
qualifies them as sophisticated  investors,  and therefore capable of evaluating
the merits and risks of this transaction.

     SELLER  acknowledges  receipt  of a copy of the  Prospectus  dated June 30,
1993,  which is attached  hereto as Exhibit B and made a part of this Agreement,
setting forth the relevant terms,  conditions and  disclosures of PURCHASER,  as
well as such other  information  as SELLER deems  necessary or  appropriate as a
prudent  sophisticated and knowledgeable  investor in evaluating the acquisition
of PURCHASER'S  shares and making this Agreement.  SELLER has carefully read the
Prospectus,  including  particularly the portion thereof entitled "Risk Factors"
and  acknowledges  that PURCHASER has made  available the  opportunity to obtain
additional  information to verify the accuracy of the  information  contained in
the Prospectus and to evaluate the merits and risks of this transaction.  SELLER
acknowledges  that they have had the  opportunity  to ask questions of PURCHASER
and CAPITAL  GENERAL and have  received  satisfactory  answers  from  PURCHASER,
CAPITAL GENERAL, or its affiliates, associates or employees concerning the terms
and conditions of this transaction and the information in the Prospectus.

     SELLER  covenants and warrants that the shares of common stock of PURCHASER
to be received by them pursuant to this  agreement are being  acquired for their
own account and for  investment and not with the present view toward the sale or
distribution in the United States thereof and will not be disposed of except (i)
pursuant to an effective  registration  statement  under the  Securities  Act of
1933, as amended, or (ii) another transaction,  which, in the opinion of counsel
acceptable to PURCHASER, is exempt from registration under the Securities Act of
1933, as amended,  or the rules and  regulations  of the Securities and Exchange
Commission  thereunder.  In order to effectuate the covenants of this paragraph,
an  appropriate  endorsement  will be placed on the  certificates  for shares of
common stock of PURCHASER  delivered to SELLER  pursuant to this  agreement  and
stop  transfer  instructions  shall be placed  with the  transfer  agent for the
securities.

                                     Page 3

<PAGE>


     SELLER  is aware  that the  shares  distributed  to him will not have  been
registered  pursuant to the Securities Act of 1933, as amended;  and, therefore,
under current  interpretations  and applicable rules,  particularly Rule 144 and
Regulation  S, he will  probably  have to retain  such shares for a period of at
least one (1) year and at the expiration of such one-year period his sale may be
confined to brokerage  transactions of limited amounts  requiring a notification
filing  on Form  144  with  the  Securities  and  Exchange  Commission  and such
disposition  may be  available  only if the  PURCHASER is current in his filings
with the  Securities  and  Exchange  Commission  and SELLER is aware of Rule 144
issued by the  Securities  and Exchange  Commission  under the Securities Act of
1933, as amended, and the other limitations imposed thereby on their disposition
of PURCHASER'S shares.

     SELLER is aware that there can be no assurance regarding the individual tax
consequences  of this  transaction,  nor can  there  be any  assurance  that the
Internal  Revenue  Code or the  regulation  promulgated  thereunder  will not be
amended  in such  manner as to  deprive  SELLER of any tax  benefit  that  might
otherwise be received.  SELLER is relying upon the advice of their  personal tax
advisor with respect to the tax aspects of this transaction.

     SELLER  acknowledges  that it is his  responsibility  to  comply  with  the
appropriate  state  and  federal  securities  laws,  as well as NASD  rules  and
regulations,  particularly secondary trading requirements. SELLER agrees to list
PURCHASER in either Moody's Investor  Services or Standard and Poors,  exempting
secondary  trading  of  PURCHASER'S  stock in those  states  providing  for such
secondary trading exemption.

REPRESENTATIONS AND WARRANTIES OF PURCHASER

     To the knowledge of the officers of PURCHASER,  PURCHASER is not a party to
nor bound by any agreement,  deed, lease,  power of attorney or other instrument
other than which is herein  disclosed.  PURCHASER has executed an Agreement with
National Stock Transfer, Inc., a transfer agency company affiliated with CAPITAL
GENERAL  CORPORATION.  A copy of this  agreement is available for  inspection by
SELLER.

     PURCHASER  represents and warrants that it is a corporation duly organized,
validly  existing and in good standing under the laws of the state of Nevada and
that the execution and  performance  of this agreement and the issuance of stock
contemplated hereby have been authorized by the board of directors of PURCHASER.
The  shares  of  PURCHASER'S  common  stock  to be  delivered  pursuant  to this
agreement,  when so delivered,  will have been duly and validly  authorized  and
issued by PURCHASER and will be fully-paid and nonassessable.

     SELLER hereby further  acknowledges and agrees that no  representations  or
warranties have been made by PURCHASER or CAPITAL GENERAL  CORPORATION as to the
benefits to be derived by SELLER in completing this transaction. It is expressly
understood and agreed that neither CAPITAL GENERAL  CORPORATION nor PURCHASER or
its  officers  or agents  have made any  warranty  or  agreement,  expressed  or
implied,  as  to  the  tax  or  securities   consequences  of  the  transactions
contemplated  by this  agreement or the tax or  securities  consequences  of any
action pursuant to or growing out of this agreement.

                                     Page 4

<PAGE> 

ACTIONS PRIOR TO CLOSING

     SELLER  shall duly comply with all  applicable  laws as may be required for
the valid and effective transfer of property,  assets and business  contemplated
by this agreement.

     The  representations  and warranties made by PURCHASER in this agreement or
given on its behalf  hereunder shall be  substantially  accurate in all material
respects  on and as of the  closing  date with the same  effect  as though  such
representations  and  warranties had been made or given on and as of the closing
date.

     SELLER  shall  perform  and  comply  with all its  obligations  under  this
agreement  which are to be performed  and complied with by it prior to or on the
closing date including the delivery of its documents specified herein.

     This Agreement  shall have been approved by the boards of directors of both
PURCHASER and SELLER.

LAW GOVERNING

     It  is  understood  and  agreed  that  all  communications,   negotiations,
meetings,  agreements and  understandings  relative to this Agreement have taken
place  in  or  from  the  state  of  Nevada  or  the  state  of  Washington.  NO
communications,  offerings,  proposals or other forms of negotiations  have been
conducted in or from the state of Utah.  This  agreement  may not be modified or
terminated orally, and shall be construed and interpreted  according to the laws
of the State of Nevada and enforced in its courts.

     Any and all disputes and controversies of every kind and nature between the
parties  hereto  arising out of or relating  to this  Agreement  relating to the
existence,  construction,  validity,  interpretation  or  meaning,  performance,
non-performance,  enforcement,  operation,  breach,  continuance  or termination
thereof shall be subject to an arbitration mutually agreeable to the parties or,
in the  absence  of such  mutual  agreement,  then  subject  to  arbitration  in
accordance  with the rules of the American  Arbitration  Association.  It is the
intent of the  parties  hereto  and the  purpose of this  provision  to make the
submission to  arbitration of any dispute or  controversy  arising  hereunder an
express  condition  precedent to any legal or equitable  action or proceeding of
any nature whatsoever.

ASSIGNMENT, AMENDMENT AND MODIFICATION

     This  agreement  shall not be  assigned  by any party  without  the written
consent of the other. PURCHASER and SELLER may amend, modify and supplement this
agreement in such manner as may be agreed upon by them in writing.

                                     Page 5

<PAGE>

TERMINATION AND ABANDONMENT

     This agreement may be terminated and the transactions  provided for by this
agreement  may be  abandoned  without  liability on the part of any party to any
other,  at any time before the closing date by mutual  consent of PURCHASER  and
SELLER.  In the  event of  termination  and  abandonment  by any party as herein
provided,  written notice shall forthwith be given to the other party,  and each
party shall pay its own expenses incident to preparation for the consummation of
this agreement and the transactions  contemplated  hereunder.  In the event that
this  Agreement has not been completed by the closing date or within thirty days
thereafter,  this Agreement and the  transactions  contemplated  hereby shall be
deemed to have been  abandoned  and  neither  party  shall be under any  further
obligation to the other. In the event of such termination or abandonment, SELLER
shall  forfeit  any  deposits,  payments  or  other  consideration  tendered  in
connection  with the execution of this  Agreement,  unless  otherwise  expressly
provided herein.

NOTICES

     All notices,  requests, demands and other communications hereunder shall be
deemed to have been duly given,  if  delivered  by hand or mailed,  certified or
registered mail with postage prepaid:

                  (a)  If to PURCHASER:
                  1800 E. Sahara, Suite 107
                  Las Vegas, Nevada  89104

                  (b)  If to SELLER:
                  c/o Axel J. Kutscher
                  Muensterstrasse 306
                  40470 Dusseldorf, Germany

ENTIRE AGREEMENT

     This instrument  embodies the entire  agreement  between the parties hereto
with respect to the transactions  contemplated  herein,  and there have been and
are no agreements,  representations or warranties between the parties other than
those set  forth or  provided  for  herein.  Any  announcements,  amendments  or
modifications shall be set forth in writing and approved by the parties hereto.

     This agreement may be executed  simultaneously in two or more counterparts,
each of which  shall be  deemed an  original,  but all of which  together  shall
constitute one and the same instrument.

FURTHER DOCUMENTS

     PURCHASER  and SELLER agree to execute any and all other  documents  and to
take such other action or corporate proceedings as may be necessary or desirable
to carry out the terms hereof.

                                     Page 6
      
<PAGE>

     IN WITNESS  WHEREOF,  the parties  hereto have caused this  agreement to be
duly executed all as of the day and year first above written.

                           BONITO INDUSTRIES, INC. ("PURCHASER")



                           /S/ Krista Nielson
                           ------------------------------------- 
                           By: Krista Nielson, President



                           EURO-AMERICAN GMBH ("SELLER")


                           /S/ Axel J. Kutscher
                           -------------------------------------
                           By: Axel J. Kutscher, Vice President


                           LABOSERVE GMBH ("SELLER")


                           /S/ Axel J. Kutscher
                           -----------------------------------------
                           By:   Axel J. Kutscher, Authorized Agent


                                     Page 7

<PAGE>


                                    EXHIBIT 1

                                    AGREEMENT
         Between

     PACE Diagnostics, Inc. an Ontario Corporation having its principal place of
business at 120 W. Beaver Creek Road, Unit 16, Richmond Hill, Ontario, Canada 48
11.2

     - hereinafter referred to as PACE -

     and

     Laboserv s.r.1., a limited  corporation duly organized under the law of the
Republic of San Marino having its principal  place of business at Via C. Canto N
18.47081 Rep. di San Marino

     - hereinafter referred to as Laboserv -

                                   Appointment

     (1) PACE hereby appoints Laboserv as its sole and exclusive distributor for
the sale of the HIV-Logic Test  (hereinafter  referred to as Product) within the
Territory as defined herein. The distribution rights are personal and may not be
reassigned  without the written  approval of PACE.  Such  approval  shall not be
unreasonably withheld.

     (2)  PACE  shall  sell  directly  to  Laboserv  but may  ship to  locations
specified by Laboserv. Orders shall be at least 50,000 tests.

     (3) Laboserv  shall not act as an agent of PACE or make any  representation
on behalf of PACE.

     (4) PACE  reserves the right to make changes to the Product but  guarantees
that these will  always be  improvements  and further  guarantees  that all such
improvements will be in product sold to Laboserv.

     (5) Laboserv  shall not sell the Product  outside of the defined  Territory
unless Laboserv has the written permission of PACE.

     (6)  During  the term of this  Agreement  and for a period  of one (1) year
after its termination Laboserv shall not sell any other HIV test.

     (7) PACE warrants that it has the  authority to make this  appointment  and
further warrants that it has no knowledge of any impediments to this action.

                                    Territory

     The Territory shall include:  all of the countries  normally referred to as
being in Europe and shall also include Russia.

                                     Page 1
      
<PAGE>
                                    Trademark

     (1) Laboserv shall have the right to use the trademark HIV Logic within the
Territory.

     (2) PACE shall indemnify  Laboserv against any legal challenges arising out
of his use of the trademark.

     (3) Laboserv may also register  other  trademarks for the Product and shall
indemnify PACE against any and all legal costs arising out of these  trademarks.
Upon termination of this Agreement all such trademarks shall become the property
of PACE.

                                   Patents

     PACE  warrants  that the Product is covered by US and European  patents and
shall indemnify Laboserv against any legal challenges to these patents.

                                    Delivery

     PACE warrants that it can deliver at least 250,000 tests per month and that
deliveries  shall be made within  four (4) to six (6) weeks after  receipt of an
order from Laboserv.

                               Pricing and Payment

     See Appendix A Attached.

                                   Warranties

     (1) PACE  warrants  that the  Product  shall be free  from all  defects  in
materials  and  workmanship  and shall be fit for the  purpose  for which it was
designed. No other claims are made.

     (2) Laboserv  warrants  that it shall hold PACE  harmless  from any and all
claims arising out of any actions initiated by Laboserv.

                                    Duration

     (1) The Agreement  shall become  effective on the date of signature by both
parties and shall remain in effect for a period of five (5) years with an option
to renew for a further five (5) years. If either side does not wish to renew the
Agreement, then at lest six months notice in writing shall be given to the other
party prior to its expiration.

     (2) If sales,  at the end of 1998,  are less than  500,000  tests then PACE
reserves the right to renegotiate this Agreement.

                                     Page 2
<PAGE>      

     (3) Minimum  sales to retain  exclusivity  shall be  negotiated  during the
fourth calendar quarter of each year.

                                  Renunciation

     The  non-compliance  of either of the  parties  at any time with one of the
clauses of this Agreement,  or the failure to exercise any right provided for in
the Agreement, or the failure at any time to demand the performance of the other
part in respect of this Agreement or any of the  provisions,  will not under any
circumstances  affect the validity of this  Agreement nor the right of the other
party to ensure compliance with the provisions.

     The  renunciation  of a provision,  condition or requirement  whatsoever of
this  Agreement,  on one or more occasions,  by either of the parties,  will not
constitute a renunciation  of any future  obligation to fulfill said  provision,
condition or requirement in respect of this Agreement.

                                     Default

     If either  party shall fail to perform or defaults  in the  performance  or
non-performance of any material provision of this Agreement, and if such failure
or default shall  continue for ninety (90) days after written  notice thereof to
the defaulting party, during which time the parties will cooperate in good faith
to solve  the  situation,  then the  non-defaulting  party  may  terminate  this
Agreement forthwith on notice to the other party.

                                  Force Majeure

     No liability  shall result to either  party from delays in  performance  or
non-performance  caused  by  circumstances  beyond  the  control  of  the  party
affected,  including,  but not limited to acts of God, fire,  flood,  explosion,
war, or action or request by government authority.

                                 Confidentiality

     During  the term of this  Agreement,  PACE and  Laboserv  shall  treat  all
confidential  information  received from the as exclusive  property of the other
party and each party agrees not to disclose or use any such  information  to any
third party without first obtaining the other party's consent.

                                     Notice

     Any notice or communication authorized or required to be given hereunder or
for the purpose  hereof shall be duly given if sent by prepaid  registered  post
and sent to the registered office to the other party hereto.

                                  Governing Law

     (1) This  Agreement  shall be  construed  under the Laws of the Province of
Ontario, Canada.

                                     Page 3

<PAGE>
      
     (2) Any dispute,  controversy  or claim arising out of, or relating to this
Agreement,  or the termination or validity thereof shall be settled through bona
fide  negotiations  between  the  parties,  but should the  parties be unable to
resolve  such  disputes  then the matter  shall be  referred to  arbitration  in
accordance with the  International  Rules of Conciliation and Arbitration of the
Zurich Chamber of Commerce.

     (3) Should no  acceptable  remedies  from this  process,  the matter  shall
proceed to litigation in the Province of Ontario, Canada.

     (4) All  stipulations  contained in this Agreement shall be so construed as
not to infringe the  provisions of any laws;  but if any such  stipulation  does
infringe  the  provision  of any law the  same  shall be  deemed  to be void and
severable.  In such event,  invalid  stipulations  shall be suitable  amended to
maintain the economic intentions of the parties hereto.

     (5)  Modifications and amendments to this Agreement shall be effective only
in the form of written instruments duly executed by both parties.

     In witness  whereof,  the parties have caused this Agreement to be executed
by their duly authorized representatives.

PACE Diagnostics Inc.                        Laboserv s.r.l.


/S/ Dr. Jeremy Clapp                         /S/ C. Galbucci
- -------------------------                    --------------------------------
By:   Dr. Jeremy Clapp                       By: C. Galbucci


                                     Page 4


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission